ClinicaliQ Trial Snapshot
- Collection of Blood Samples for New Diagnostic Devices 2 — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT05568966.
- What is being tested: Development and validation of new diagnostic biomarkers on the LumiraDx Platform, with comparative evaluation against established gold standard reference methods to ensure clinical accuracy and reliability.
- Patient eligibility overview: The trial recruits individuals across various health conditions who can provide blood samples for biomarker analysis; specific eligibility criteria depend on the particular diagnostic being evaluated and the comparison requirements against reference standards.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
To research and develop new state of the art diagnostic biomarkers on the LumiraDx Platform that are comparable to the approved gold standard reference methods and will radically enhance clinicians and patients ability to monitor health conditions and improve outcomes by delivering the results near patient at the point of care.
Eligibility Snapshot
- * Subject 18 years of age. * Willing and able to provide written informed consent and comply with study procedures. * Patients attending a definitive care team with research capabilities which has been enroled in this collection study. * Patients who can read and understand written English. * The subject must present as one of the following cohorts: 1. Group A - Embolism Cohort - Patients presenting with symptoms indicative of thromboembolic events. 2. Group B - Infection or Inflammation Cohort - Patients presenting with symptoms indicative of infection or inflammatory disorders. 3. Group C - Cardiovascular Cohort - Patients presenting with symptoms indicative of heart failure or acute coronary syndrome. 4. Group D - Renal Cohort - Patients presenting with symptoms indicative of renal disorders. 5. Group E - Other Cohort. - Patients who are not eligible for any of the above groups.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.